These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17440055)

  • 21. Transgenic Polyoma middle-T mice model premalignant mammary disease.
    Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL
    Cancer Res; 2001 Nov; 61(22):8298-305. PubMed ID: 11719463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
    Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
    Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.
    Hulit J; Suyama K; Chung S; Keren R; Agiostratidou G; Shan W; Dong X; Williams TM; Lisanti MP; Knudsen K; Hazan RB
    Cancer Res; 2007 Apr; 67(7):3106-16. PubMed ID: 17409417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
    Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
    Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
    Robinson GW; Wagner KU; Hennighausen L
    Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
    Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
    Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer.
    Cuevas BD; Winter-Vann AM; Johnson NL; Johnson GL
    Oncogene; 2006 Aug; 25(36):4998-5010. PubMed ID: 16568086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer.
    Guillory B; Sakwe AM; Saria M; Thompson P; Adhiambo C; Koumangoye R; Ballard B; Binhazim A; Cone C; Jahanen-Dechent W; Ochieng J
    Am J Pathol; 2010 Nov; 177(5):2635-44. PubMed ID: 20847285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
    Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.
    Bengsch F; Buck A; Günther SC; Seiz JR; Tacke M; Pfeifer D; von Elverfeldt D; Sevenich L; Hillebrand LE; Kern U; Sameni M; Peters C; Sloane BF; Reinheckel T
    Oncogene; 2014 Sep; 33(36):4474-84. PubMed ID: 24077280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis.
    Xue C; Wyckoff J; Liang F; Sidani M; Violini S; Tsai KL; Zhang ZY; Sahai E; Condeelis J; Segall JE
    Cancer Res; 2006 Jan; 66(1):192-7. PubMed ID: 16397232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence-Activated Cell Sorting of Murine Mammary Cancer Stem-Like Cell Subpopulations with HIF Activity.
    Brooks DL; Seagroves TN
    Methods Mol Biol; 2018; 1742():247-263. PubMed ID: 29330806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice.
    Ahmed F; Wyckoff J; Lin EY; Wang W; Wang Y; Hennighausen L; Miyazaki J; Jones J; Pollard JW; Condeelis JS; Segall JE
    Cancer Res; 2002 Dec; 62(24):7166-9. PubMed ID: 12499251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
    Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
    Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line.
    Ford HL; Salim MM; Chakravarty R; Aluiddin V; Zain SB
    Oncogene; 1995 Nov; 11(10):2067-75. PubMed ID: 7478526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo.
    Attalla S; Taifour T; Bui T; Muller W
    Oncogene; 2021 Jan; 40(3):475-491. PubMed ID: 33235291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo.
    Goswami S; Philippar U; Sun D; Patsialou A; Avraham J; Wang W; Di Modugno F; Nistico P; Gertler FB; Condeelis JS
    Clin Exp Metastasis; 2009; 26(2):153-9. PubMed ID: 18985426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stefin B deficiency reduces tumor growth via sensitization of tumor cells to oxidative stress in a breast cancer model.
    Butinar M; Prebanda MT; Rajković J; Jerič B; Stoka V; Peters C; Reinheckel T; Krüger A; Turk V; Turk B; Vasiljeva O
    Oncogene; 2014 Jun; 33(26):3392-400. PubMed ID: 23955077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.